PDS Biotechnology
PDSB
PDSB
52 hedge funds and large institutions have $137M invested in PDS Biotechnology in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
1.3%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
9
Increased
19
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $1K | -$4K | -16 | -80% |
|
52
BNP Paribas Financial Markets
Paris,
France
| $747 | -$7.66K | -41 | -91% |
|
53
Goldman Sachs
New York
| – | -$361K | -1,445 | Closed |
|
54
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$328K | -1,312 | Closed |
|
55
LPL Financial
San Diego,
California
| – | -$162K | -634 | Closed |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| – | -$1K | -3 | Closed |
|